Medication treatment of bipolar disorder in developmentally disabled children and adolescents

Minerva Pediatrica

Volumn 60, Issue 1, 2008, Pages 69-85

  Gutkovich, Z A ^a   Carlson, G A ^b  

^a ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

Adolescent; Autistic disorder, therapy; Bipolar disorder, therapy; Child; Mental retar dation, therapy

Indexed keywords

ARIPIPRAZOLE; CARBAMAZEPINE; CHLORPROMAZINE; CLOZAPINE; FLUOXETINE PLUS OLANZAPINE; LAMOTRIGINE; LITHIUM; METHYLPHENIDATE; OLANZAPINE; OXCARBAZEPINE; QUETIAPINE; RISPERIDONE; TOPIRAMATE; VALPROATE SEMISODIUM; VALPROIC ACID; ZIPRASIDONE;

ARTICLE; ATTENTION DEFICIT DISORDER; BIPOLAR DISORDER; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; DISEASE SEVERITY; DRUG SAFETY; DRUG TOLERABILITY; FOLLOW UP; HUMAN; HYPERKINESIA; PRACTICE GUIDELINE;

ADOLESCENT; ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; ANTIMANIC AGENTS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; CHILD; DISABLED CHILDREN; DRUG THERAPY, COMBINATION; ELECTROCONVULSIVE THERAPY; EVIDENCE-BASED MEDICINE; HUMANS; TREATMENT OUTCOME;

EID: 42049085301     PISSN: 00264946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (90)

1. Gillberg C. Autism and pervasive developmental disorders. J Child Psychol Psychiatry 1990;31:99-119.
2. Rutter M, Bailey A, Bolton P, Le Couteur A. Autism and known medical conditions: myth and substance. J Child Psychol Psychiatry 1994;35:311-22.
3. th rev ed. Washington DC: American Psychiatric Association; 2000.
4. Stahlberg O, Soderstrom H, Rastam M, Gillberg C. Bipolar disorder, schizophrenia, and other psychotic disorders in adults with childhood onset AD/HD and/or autism spectrum disorders. J Neural Transm 2004;111:891-902.
5. Kerbeshian J, Burd L. Case study: comorbidity among Tourette's syndrome, autistic disorder, and bipolar disorder. J Am Acad Child Adolesc Psychiatry 1996,35:681-5.
6. Wozniak J, Biederman J, Faraone SV, Frazier J, Kim J, Millstein R et al. Mania in children with pervasive developmental disorder revisited. J Am Acad Child Adolesc Psychiatry 1997;36:1552-9.
7. Kennedy SH, Kutcher SP, Ralevski E, Brown GM. Nocturnal melatonin 18 and 24-hour 6-sulphatoxymelatonin levels in various phases of bipolar affective disorder. Psychiatry Res 1996;63:219-22.
8. Melke J, Goubran Botros H, Chaste P, Betancur C, Nygren G, Anckarsäter H et al. The PARIS Study. Abnormal melatonin synthesis in autism spectrum disorder. Mol Psychiatry 2007.[Epub ahead of print].
9. Tordjman S, Anderson GM, Pickard N, Chaarbuy H, Touitou Y. Nocturnal excretion of 6-sulphatoxymelatonin in children and adolescents with autistic disorder. Biol Psychiatry 2005;57:134-8.
10. Harvey AG, Mullin BC, Hinshaw SP. Sleep and circadian rhythms in children and adolescents with bipolar disorder. Dev Psychopathol 2006;18:1147-68.
11. Limoges E, Mottron L, Bolduc C, Berthiaume C, Godbout R. Atypical sleep architecture and the autism phenotype. Brain 2005;128:1049-61.
12. DeLong GR, Dwyer JT. Correlation of family history with specific autistic subgroups: Asperger's syndrome and bipolar affective disease. J Autism Dev Disord 1988;18:593-600.
13. Rzhetsky A, Wajngurt D, Park N, Zheng T. Probing genetic overlap among complex human phenotypes. Proc Natl Acad Sci U S A 2007;104:1694-9.
14. Bradley E, Bolton P. Episodic psychiatric disorders in teenagers with learning disabilities with and without autism. Br J Psychiatry 2006;189:361-6.
15. McCracken JT, McGough J, Shah B, Cronin P, Hong D, Aman MG et al. Research Units on Pediatric Psychopharmacology Autism Network. Risperidone in children with autism and serious behavioral problems. N Eng J Med 2002;347:314-21.
16. Aman MG, De Smedt G, Derivan A, Lyons B, Findling RL. Risperidone Disruptive Behavior Study Group. Double-blind, PBO-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence. Am J Psychiatry 2002;159:1337-46.
17. Achenbach TM. Manual for the Child Behavior Checklist 4-18 and 1991 Profile. Burlington: University of Vermont, Psychiatry Department; 1991.
18. Mick E, Biederman J, Pandina G, Faraone SV. A preliminary meta-analysis of the child behavior checklist in pediatric bipolar disorder. Biol Psychiatry 2003;53:1021-7.
19. Biederman J, Mick E, Faraone SV, Wozniak J, Spencer T, Pandina G. Risperidone for the treatment of affective symptoms in children with disruptive behavior disorder: a post hoc analysis of data from a 6-week, multicenter, randomized, double-blind, parallel-arm study. Clin Ther 2006;28:794-800.
20. Aman MG, Tassé MJ, Rojahn J, Hammer D. The Nisonger CBRF: a child behavior rating form for children with developmental disabilities. Res Dev Disabil 1996;17:41-57.
21. Aman MG, Singh NN, Stewart AW, Field CJ. The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects. Am J Ment Defic 1985;89:485-91.
22. Towbin KE, Pradella A, Gorrindo T, Pine D, Leibenluft E. Autism Spectrum Traits in Children with Mood and Anxiety Disorders. J Child Adolesc Psychopharmacol 2005;15:452-64.
23. DeJong S, Frazier JA. Bipolar Disorder in Children with Pervasive Developmental Disorder. In: Geller B, DelBello MP, editors. Bipolar Disorder in Childhood and Early Adolescence. New York: Guildford Press; 2002. p. 51-75.
24. Carlson GA, Meyer SE. Diagnosis of bipolar disorder across the lifespan: complexities and developmental issues. Dev Psychopathol 2006;18:939-69.
25. Kerbeshian J, Burd L, Fisher W. Lithium carbonate in the treatment of two patients with infantile autism and atypical bipolar symptomatology. J Clin Psychopharmacol 1987;7:401-5.
26. Hurley AD. Mood disorders in intellectual disability. Curr Opin Psychiatry 2006;19:465-9.
27. Gutkovich ZA, Carlson GA, Carlson HE, Coffey B, Wieland N. Asperger's disorder and co-morbid bipolar disorder: diagnostic and treatment challenges. J Child Adolesc Psychopharmacol 2007;17:247-55.
28. Gonzalez M, Matson JL. Mania and intellectual disability: the course of manic symptoms in persons with intellectual disability. Am J Ment Retard 2006;111:378-83.
29. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978;133:429-35.
30. Matson JL, Terlonge C, Gonzalez ML, Rivet T. An evaluation of social and adaptive skills in adults with Bipolar Disorder and severe/profound intellectual disability. Res Dev Disabil 2006;27:681-7.
31. Cain NN, Davidson PW, Burhan AM, Andolsek ME, Baxter JT, Sullivan L et al. Identifying bipolar disorders in individuals with intellectual disability. J Intellect Disabil Res 2003;47(Pt 1):31-8.
32. Ruedrich S. Bipolar mood disorders in persons with mental retardation: Assessment and diagnosis. In: Fletcher RJ, Dosen A, editors. Mental health aspects of mental retardation: Progress in assessment and treatment. New York: Lexington Books; 1993. p. 111-29.
33. Lowry MA. Behavioral psychology update: A clear link between problem behaviors and mood disorders. The Habilitative Mental Healthcare Newsletter 1993;12:105-10.
34. Carlson GA. Affective psychoses in mental retardates. Psychiatr Clin North Am 1979;2:499-510.
35. Hasan MK, Mooney RP. Three cases of manic-depressive illness in mentally retarded adults. Am J Psychiatry 1979;136:1069-71.
36. Naylor GJ, Donald JM, Le Poidevin D, Reid AH. A double-blind trial of long-term lithium therapy in mental defectives. Br J Psychiatry 1974;124:52-7.
37. Reid AH, Naylor GJ, Kay DS. A double-blind, placebo controlled, crossover trial of carbamazepine in overactive, severely mentally handicapped patients. Psychol Med 1981;11:109-13.
38. Sovner R, Hurley A. The management of chronic behavior disorders in mentally retarded adults with lithium carbonate. J Nerv Ment Dis 1981;169:191-5.
39. Damore J, Stine J, Brody L. Medication-induced hypomania in Asperger's disorder. J Am Acad Child Adolesc Psychiatry 1998;37:248-9.
40. Annell AL. Lithium in the treatment of children and adolescents. Acta Psychiatr Scand Suppl 1969;207:19-33.
41. Sovner R. The diagnosis and treatment of manic-depressive illness in childhood and adolescence. Psychiatry Opin 1975:37-42.
42. Greenhill LL, Rieder RO, Wender PH, Buchsbaum M, Zhan TP. Lithium carbonate in the treatment of hyperactive children. [Clinical Trial. Journal Article. Randomized Controlled Trial.] Arch Gen Psychiatry 1973;28:636-40.
43. Kafantaris V, Coletti DJ, Dicker R, Padula G, Kane JM. Lithium treatment of acute mania in adolescents: a large open trial. J Am Acad Child Adolesc Psychiatry 2003;42:1038-45.
44. Kafantaris V, Coletti DJ, Dicker R, Padula G, Pleak RR, Alvir JM. Lithium treatment of acute mania in adolescents: a placebo-controlled discontinuation study. J Am Acad Child Adolesc Psychiatry 2004;43:984-93.
45. Strober M, Morrell W, Lampert C, Burroughs J. Relapse following discontinuation of lithium maintenance therapy in adolescents with bipolar I illness: a naturalistic study. Am J Psychiatry 1990;147:457-61.
46. Gram LF, Rafaelsen OJ. Lithium treatment of psychotic children and adolescents. A controlled clinical trial. Acta Psychiatr Scand 1972;48:253-60.
47. Campbell M, Fish B, Korein J, Shapiro T, Collins P, Koh C. Lithium and chlorpromazine: a controlled crossover study of hyperactive severely disturbed young children. J Autism Child Schizophr 1972;2:234-63.
48. Adams GL, Kivowitz J, Ziskind E. Manic depressive psychosis, mental retardation, and chromosomal rearrangement. Arch Gen Psychiatry 1970;23:305-9.
49. Kelly JT, Koch M, Buegel D. Lithium carbonate in juvenile manic-depressive illness. Dis Nerv Syst 1976;37:90-2.
50. Goetzl U, Grunberg F, Berkowitz B. Lithium carbonate in the management of hyperactive aggressive behavior of the mentally retarded. Compr Psychiatry 1977;18:599-606.
51. Steingard R, Biederman J. Lithium responsive manic-like symptoms in two individuals with autism and mental retardation. J Am Acad Child Adolesc Psychiatry 1987;26:932-5.
52. Fukuda K, Etoh T, Okuma T. Affective disorders in mentally retarded adolescents - report of two cases with lithium treatment. Jpn J Psychiatry Neurol 1986;40:551-7.
53. Linter CM. Short-cycle manic-depressive psychosis in a mentally handicapped child without family history. A case report. Br J Psychiatry 1987;151:554-5.
54. McCracken JT, Diamond RP. Bipolar Disorder in Mentally Retarded Adolescents. J Am Acad Child Adolesc Psychiatry 1988;4:494-9.
55. Frazier JA, Doyle R, Chiu S, Coyle JT. Treating a child with Asperger's disorder and comorbid bipolar disorder. Am J Psychiatry 2002;159:13-21.
56. Campbell M, Small AM, Green WH, Jennings SJ, Perry R, Bennett WG et al. Behavioral efficacy of haloperidol and lithium carbonate. A comparison in hospitalized aggressive children with conduct disorder. Arch Gen Psychiatry 1984;41:650-6.
57. Malone RP, Delaney MA, Luebbert JF, Cater J, Campbell M. A double-blind placebo-controlled study of lithium in hospitalized aggressive children and adolescents with conduct disorder. Arch Gen Psychiatry 2000;57:649-54.
58. Dostal T, Zvolsky P. Antiagressive effects of lithium salts in severe mentally retarded adolescents. Int Pharmacopsychiatry 1970;5:203-7.
59. Stoner SC, Nelson LA, Lea JW, Marken PA, Sommi RW, Dahmen MM. Historical review of carbamazepine for the treatment of bipolar disorder. Pharmacotherapy 2007;27:68-88.
60. Kowatch RA, Suppes T, Carmody TJ, Bucci JP, Hume JH, Kromelis M et al. Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder. J Amer Acad Child and Adolesc Psychiatry 2000;39:713-20.
61. Komoto J, Usui S, Hirata J. Infantile autism and affective disorder. J Autism Dev Disord 1984;14:81-4.
62. Macritchie K, Geddes JR, Scott J, Haslam D, de Lima M, Goodwin G. Valproate for acute mood episodes in bipolar disorder. Cochrane Database Syst Rev 2003;(1):CD 004052.
63. Carlson GA, collaborator. Treatment of bipolar disorder in children and adolescents In: Goodwin FK, Jamison KR. Manic Depressive Illness: Bipolar disorders and recurrent depression. 2nd ed. Oxford: Oxford University Press; 2007. p. 907-35.
64. Kastner T, Friedman DL, Plummer AT, Ruiz MQ, Henning D. Valproic acid for the treatment of children with mental retardation and mood symptomatology. Pediatrics 1990;86:467-72.
65. Kastner T, Friedman DL. Verapamil and valproic acid treatment of prolonged mania. J Am Acad Child Adolesc Psychiatry 1992;31:271-5.
66. Whittier MC, West SA, Galli VB, Raute NJ. Valproic acid for dysphoric mania in a mentally retarded adolescent. J Clin Psychiatry 1995;56:590-1.
67. Kastner T, Finesmith R, Walsh K. Long-term administration of valproic acid in the treatment of affective symptoms in people with mental retardation. J Clin Psychopharmacol 1993;13:448-51.
68. Hollander E, Dolgoff-Kaspar R, Cartwright C, Rawitt R, Novotny S. An open trial of divalproex sodium in autism spectrum disorders. J Clin Psychiatry 2001;62:530-4.
69. Hellings JA, Weckbaugh M, Nickel EJ, Cain SE, Zarcone JR, Reese RM et al. A double-blind, placebo-controlled study of valproate for aggression in youth with pervasive developmental disorders. J Child Adolesc Psychopharmacol 2005;15:682-92.
70. Tohen M, Kryzhanovskaya L, Carlson G, Delbello M, Wozniak J, Kowatch R et al. Olanzapine versus placebo in the treatment of adolescents with bipolar mania. Am J Psychiatry 2007;164:1547-56.
71. Hellings JA, Zarcone JR, Reese RM, Valdovinos MG, Marquis JG, Fleming KK et al. A crossover study of risperidone in children, adolescents and adults with mental retardation. J Autism Dev Disord 2006;36:401-11.
72. Turgay A, Binder C, Snyder R, Fisman S. Long-term safety and efficacy of risperidone for the treatment of disruptive behavior disorders in children with subaverage IQs. Pediatrics 2002;110:e34.
73. Corson AH, Barkenbus JE, Posey DJ, Stigler KA, McDougle CJ. A retrospective analysis of quetiapine in the treatment of pervasive developmental disorders. J Clin Psychiatry 2004;65:1531-6.
74. Hardan AY, Jou RJ, Handen BL. Retrospective study of quetiapine in children and adolescents with pervasive developmental disorders. J Autism Dev Disord 2005;35:387-91.
75. Thuppal M, Fink M. Electroconvulsive therapy and mental retardation. J ECT 1999;15:140-9.
76. Guze BH, Weinman B, Diamond RP. Use of ECT to Treat Bipolar Depression in a Mental Retardate with Cerebral Palsy. Convuls Ther 1987;3:60-4.
77. Carlson GA, Mick E. Drug-Induced Disinhibition in Psychiatrically Hospitalized Children. J Child Adolesc Psychopharmacol 2003;13:153-64.
78. Friedman DL, Kastner T, Plummer AT, Ruiz MQ, Henning D. Adverse behavioral effects in individuals with mental retardation and mood disorders treated with carbamazepine. Am J Ment Retard 1992;96:541-6.
79. Reiss AL, O'Donnell DJ. Carbamazepine-induced mania in two children: case report. J Clin Psychiatry 1984;45:272-4.
80. Silverstein FS, Parrish MA, Johnson MV. Adverse behavior reactions in children treated with carbamazepine (Tegretol). J Pediatr 1982;101:785-7.
81. Pary R. Side effects during lithium treatment for psychiatric disorders in adults with mental retardation. Am J Ment Retard 1991;96:269-73.
82. Elliott RL. Lithium treatment and cognitive changes in two mentally retarded patients. J Nerv Ment Dis 1986;174:689-92.
83. Maruta K. Lithium intoxication in a patient with severe motor and intellectual disabilities. No To Hattatsu 2003;35:422-5.
84. Isojärvi JIT, Laatikainen TJ, Pakarinen AJ, Juntunen KT, Myllylä VV. Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy. N Engl J Med 1993;4:1383-8.
85. Klein DJ, Cottingham EM, Sorter M, Barton BA, Morrison JA. A randomized, double-blind, placebo-controlled trial of metformin treatment of weight gain associated with initiation of atypical antipsychotic therapy in children and adolescents. [See comment.] Am J Psychiatry 2006;163:2072-9.
86. American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, North American Association for the Study of Obesity. Consensus development conference on antipsychotic drugs and obesity and diabetes. J Clin Psychiatry 2004;65:267-72.
87. Allison DB, Mentore JL, Heo M, Chandler LP, Cappelleri JC, Infante MC et al. Antipsychotic-induced weight gain: a comprehensive research synthesis [see comment]. [Review] Am J Psychiatry 1999;156:1686-96.
88. Casey DE, Haupt DW, Newcomer JW, Henderson DC, Sernyak MJ, Davidson M et al. Antipsychotic-induced weight gain and metabolic abnormalities: implications for increased mortality in patients with schizophrenia. J Clin Psychiatry 2004;65(Suppl 7):4-18; quiz19-20.
89. Correll CU, Parikh UH, Mughal T, Olshanskiy V, Moroff M, Pleak RR et al. Body Composition Changes Associated with Second-Generation Antipsychotics. Biol Psychiatry 2005;57(Suppl 8):36.
90. Sovner R. Divalproex-responsive rapid cycling bipolar disorder in a patient with Down's syndrome: implications for the Down's syndrome-mania hypothesis. J Ment Deficiency Res 1991;35:171-3.